(STOK) |
| 0 (0%) 04-14 10:46 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 46.98 |
| Resistance 1: | 40.22 |
| Pivot price: | 33.58 |
| Support 1: | 33.82 |
| Support 2: | 29.86 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -18820000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | -78.824 |
| Profit Margin (%) | -3.73 |
| Operating Margin (%) | -4.00 |
| Return on Assets (ttm) | 382.2 |
| Return on Equity (ttm) | -3.7 |
Company news
Tue, 14 Apr 2026
Price-Driven Insight from (STOK) for Rule-Based Strategy - Stock Traders Daily
Tue, 14 Apr 2026
Baillie Gifford & Co. Purchases New Position in Stoke Therapeutics, Inc. $STOK - MarketBeat
Wed, 08 Apr 2026
Did Stoke’s New R&D Chair Signal a Tighter Late-Stage Focus for STOK’s Pipeline Strategy? - simplywall.st
Wed, 08 Apr 2026
Wolfe Research Initiates Coverage on Stoke Therapeutics (STOK) w - GuruFocus
Tue, 07 Apr 2026
Stoke Therapeutics (STOK) director receives 30,782-share stock option grant - Stock Titan
Mon, 06 Apr 2026
Assessing Stoke Therapeutics (STOK) Valuation After Strong 1 Year Shareholder Returns - Sahm
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
